A new model for predicting the timing of leukapheresis on the basis of CD34+ cell and hematopoietic progenitor cell levels

Journal of Clinical Apheresis

Volumn 22, Issue 4, 2007, Pages 195-203

  Teng, Hao Wei ^a,b   Hsiao, Liang Tsai ^a,b   Chaou, Shu Chou ^a,b   Gau, Jyh Pyng ^a,b   Lee, Tzu Chi ^c   Shih, Ying Yih ^a,b   Liu, Chun Yu ^a,b   Hong, Ying Chung ^a,b   Chen, Ming Huang ^a,b   Chang, Mu Hsin ^a,b   Yang, Ya Hsu ^d   Chen, Po Min ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Antigens; CD34; Evaluation studies; Hematopoietic stem cells; Leukapheresis; Stem cell transplantation

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IDARUBICIN; IFOSFAMIDE; METHYLPREDNISOLONE; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER; CD34 SELECTION; CELL COUNT; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; DEMOGRAPHY; DRUG MEGADOSE; FEMALE; GERM CELL TUMOR; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HODGKIN DISEASE; HUMAN; LEUKAPHERESIS; MALE; NONHODGKIN LYMPHOMA; PARAPROTEINEMIA; PLASMA CELL LEUKEMIA; RECEIVER OPERATING CHARACTERISTIC; SINGLE DRUG DOSE;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; CELL COUNT; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; LEUKOCYTES; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASMS; PROGNOSIS; TIME FACTORS;

EID: 34548270969     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20117     Document Type: Article

References (20)

1. Demirer T, Bensinger WI. Optimization of peripheral blood stem cell collection. Curr Opin Hematol 1995;2:219-226.
2. Watts MJ, Sullivan AM, Leverett D, Peniket AJ, Perry AR, Williams CD, Devereux S, Goldstone AH, Linch DC. Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem-cell mobilization. J Clin Oncol 1998;16: 1554-1560.
3. Anderlini P, Przepiorka D, Huh Y, Lauppe J, Miller P, Sundberg J, Seong D, Champlin R, Korbling M. Duration of filgrastim mobilization and apheresis yield of CD34+ progenitor cells and lymphoid subsets in normal donors for allogeneic transplantation. Br J Haematol 1996;93:940-942.
4. Grigg AP, Roberts AW, Raunow H, Houghton S, Layton JE, Boyd AW, McGrath KM, Maher D. Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 1995;86:4437-4445.
5. Demirer T, Buckner CD, Appelbaum FR, Petersen FB, Rowley S, Weaver CH, Lilleby K, Sanders J, Chauncey T, Storb R. Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia. Bone Marrow Transplant 1995;15:915-922.
6. Ho AD, Gluck S, Germond C, Sinoff C, Dietz G, Maruyama M, Corringham RE. Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocyte-macrophage colony-stimulating factor for autologous transplantation in advanced breast cancer. Leukemia 1993;7: 1738-1746.
7. Stewart AK, Imrie K, Keating A, Anania S, Nayar R, Sutherland DR. Optimizing the CD34+ and CD34+Thy-1+ stem cell content of peripheral blood collections. Exp Hematol 1995;23:1619-1627.
8. Elliott C, Samson DM, Armitage S, Lyttelton MP, McGuigan D, Hargreaves R, Giles C, Abrahamson G, Abboudi Z, Brennan M, Kanfer EJ. When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood. J Clin Oncol 1996;14:970-973.
9. Schots R, Van R, I, Damiaens S, Flament J, Lacor P, Staelens Y, Steenssens L, van Camp B, De Waele M. The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis. Bone Marrow Transplant 1996;17:509-515.
10. Haas R, Mohle R, Fruhauf S, Goldschmidt H, Witt B, Flentje M, Wannenmacher M, Hunstein W. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83:3787-3794.
11. Armitage S, Hargreaves R, Samson D, Brennan M, Kanfer E, Navarrete C. CD34 counts to predict the adequate collection of peripheral blood progenitor cells. Bone Marrow Transplant 1997;20:587-591.
12. Yu J, Leisenring W, Bensinger WI, Holmberg LA, Rowley SD. The predictive value of white cell or CD34+ cell count in the peripheral blood for timing apheresis and maximizing yield. Transfusion 1999;39:442-450.
13. Yu J, Leisenring W, Fritschle W, Heimfeld S, Shulman H, Bensinger WI, Holmberg LA, Rowley SD. Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500 predicts final CD34+ cell yield in the apheresis collection. Bone Marrow Transplant 2000;25:1157-1164.
14. Pollard Y, Watts MJ, Grant D, Chavda N, Linch DC, Machin SJ. Use of the haemopoietic progenitor cell count of the Sysmex SE-9500 to refine apheresis timing of peripheral blood stem cells. Br J Haematol 1999;106:538-544.
15. Takekawa K, Yamane T, Suzuki K, Hino M, Tatsumi N. Identification of hematopoietic stem cells by the SE-9000 automated hematology analyzer in peripheral blood stem cell harvest samples. Acta Haematol 1997;98:54-55.
16. Ishii T, Kawasumi I, Matsumoto H. SE-9000 IMI Channel: focusing on the roles and functions of surfactant. Sysmex J Int 1997;7: 123-128.
17. Yamane T, Takekawa K, Tatsumi N. Possibility of identification of hematopoietic stem cells using a conventional blood cell counter. Eur J Haematol 1995;55:207-208.
18. Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gandola L, Stern AC, Lansdorp PM, Bonadonna G, Gianni AM. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991;77:400-409.
19. Ford CD, Chan KJ, Reilly WF, Petersen FB. An evaluation of predictive factors for CD34+ cell harvest yields from patients mobilized with chemotherapy and growth factors. Transfusion 2003;43:622-625.
20. Benjamin RJ, Linsley L, Fountain D, Churchill WH, Sieff C, Cannon ME, Uhl L, Gaynes L, Antin JH, Wheeler C. Preapheresis peripheral blood CD34+ mononuclear cell counts as predictors of progenitor cell yield. Transfusion 1997;37:79-85.